Fiche centre
Haukeland University Hospital
Bergen — Norway
Essais liés12clinical trials
VilleBergenlocalisation
PaysNorwaylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05744310
Essais cliniques associés
12| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Discontinuation of aspirin (ATC-code B01AC06 and N02BA01) | Maladie coronarienne | Phase 4 | NCT07854795 | RELEASE-Norway — Reconsidering Long-Term Apirin in the Elderly in Secondary Prevention of Coronary Artery Disease Norway | NOT_YET_RECRUITING |
| Proton radiotherapy | Cancer | À vérifier | NCT07922967 | PRORADNOR-ReIR — Proton Re-irradiation in Patients With Recurrent or Second Primary Head and Neck Cancer , a Multicentre Phase II Single Arm Trial | RECRUITING |
| Tenecteplase | Accident vasculaire cérébral | Phase 3 | NCT07361302 | TENACITY — A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well | RECRUITING |
| Long term mechanical ventilation support | Sclérose latérale amyotrophique | Non applicable | NCT05744310 | ALS-LTMV — Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families | RECRUITING |
| Cyclophosphamide and ATG | SEP | Phase 3 | NCT03477500 | Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab for RRMS (RAM-MS) | ACTIVE_NOT_RECRUITING |
| PETRA-NMD — Personalized Training for People With Rare Neuromuscular Disorders | Myopathies | Non applicable | NCT06708468 | PETRA-NMD — Personalized Training for People With Rare Neuromuscular Disorders | RECRUITING |
| Hemanext ONE system | Cancer | Non applicable | NCT06685848 | Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion | ACTIVE_NOT_RECRUITING |
| Nipocalimab | Lupus | Phase 3 | NCT07438496 | GARDENIA-SLE — A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus | RECRUITING |
| Atorvastatin 40mg | Migraine | Phase 2 | NCT06248671 | EStatinMig — Prophylactic Treatment With Atorvastatin for Episodic Migraine. | RECRUITING |
| Atorvastatin 40mg | Migraine | Phase 2 | NCT06485336 | Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig) | RECRUITING |
| N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's Disease | Alzheimer | Phase 2 | NCT07741071 | N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's Disease | NOT_YET_RECRUITING |
| SOUL-DM1 — Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1 | Myopathies | À vérifier | NCT05006924 | SOUL-DM1 — Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1 | COMPLETED |